“…As our trauma population in the United States becomes older and the use of antiplatelet and anticoagulant agents is increasingly more common in elderly patients, questions regarding outcomes of trauma surgery for patients on these agents have become more frequent, complex, and potentially consequential. Many studies investigating outcomes of surgery in injured patients on chronic antiplatelet and anticoagulant (AP/AC) therapies have been performed in efforts to improve outcomes for these patients [ [3] , [4] , [5] , [6] , 8 , 9 ].…”